4.1 Editorial Material

Counting the cost of spinal muscular atrophy

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Gene-targeting pharmaceuticals for single-gene disorders

Arthur L. Beaudet et al.

HUMAN MOLECULAR GENETICS (2016)

Article Genetics & Heredity

Disease burden of spinal muscular atrophy in Germany

Constanze Klug et al.

ORPHANET JOURNAL OF RARE DISEASES (2016)

Article Economics

The economic burden of spinal muscular atrophy

Edward P. Armstrong et al.

JOURNAL OF MEDICAL ECONOMICS (2016)

Editorial Material Pharmacology & Pharmacy

Moving towards treatments for spinal muscular atrophy: hopes and limits

Brunhilde Wirth et al.

EXPERT OPINION ON EMERGING DRUGS (2015)

Article Neurosciences

Disease Mechanisms and Therapeutic Approaches in Spinal Muscular Atrophy

Sarah Tisdale et al.

JOURNAL OF NEUROSCIENCE (2015)

Review Clinical Neurology

Spinal muscular atrophy-recent therapeutic advances for an old challenge

Irene Faravelli et al.

NATURE REVIEWS NEUROLOGY (2015)

Review Biochemistry & Molecular Biology

UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration

Ewout J. N. Groen et al.

TRENDS IN MOLECULAR MEDICINE (2015)

Article Clinical Neurology

Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy

Michela Ripolone et al.

JAMA NEUROLOGY (2015)

Review Anatomy & Morphology

Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Monir Shababi et al.

JOURNAL OF ANATOMY (2014)

Article Medicine, Research & Experimental

Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy

Thomas M. Wishart et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Review Biochemistry & Molecular Biology

Spinal muscular atrophy: going beyond the motor neuron

Gillian Hamilton et al.

TRENDS IN MOLECULAR MEDICINE (2013)

Review Clinical Neurology

Childhood spinal muscular atrophy: controversies and challenges

Eugenio Mercuri et al.

LANCET NEUROLOGY (2012)

Article Obstetrics & Gynecology

The cost-effectiveness of prenatal screening for spinal muscular atrophy

Sarah E. Little et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)

Article Biochemistry & Molecular Biology

Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model

Melissa Bowerman et al.

HUMAN MOLECULAR GENETICS (2010)

Review Neurosciences

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Arthur H. M. Burghes et al.

NATURE REVIEWS NEUROSCIENCE (2009)